药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Triazolam
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Geranylgeranyl diphosphate.
Triazolam
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Farnesyl diphosphate.
Triazolam
Triptorelin
The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Triptorelin.
Triazolam
Histrelin
The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Histrelin.
Triazolam
Buserelin
The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Buserelin.
Triazolam
Degarelix
The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Degarelix.
Triazolam
Mepyramine
The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Mepyramine.
Triazolam
Amisulpride
The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Amisulpride.
Triazolam
Tandutinib
The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Tandutinib.
Triazolam
Ezogabine
The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Ezogabine.
Triazolam
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Farnesyl thiopyrophosphate.
Triazolam
Fleroxacin
The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Fleroxacin.
Triazolam
Vorinostat
The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Vorinostat.
Triazolam
Thiothixene
The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Thiothixene.
Triazolam
Pheniramine
The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Pheniramine.
Triazolam
Methotrimeprazine
The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Methotrimeprazine.
Triazolam
Arformoterol
The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Digitoxin.
Triazolam
Desflurane
The risk or severity of QTc prolongation can be increased when Desflurane is combined with Digitoxin.
Triazolam
Cyclizine
The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Digitoxin.
Triazolam
Levocabastine
The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Digitoxin.